Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Teva Pharmaceutical Industries

Information provided by (Responsible Party):

CureTech Ltd

ClinicalTrials.gov Identifier:

NCT00962936

First received: August 19, 2009

Last updated: October 22, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2013
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)